Clinical data | |
---|---|
Trade names | Ildamen, Modacor, Myofedrin |
Other names | Oxyfedrin; Oxyphedrine; Oxyphedrin; Oxifedrine; Oxifedrin; Oxiphedrine; Oxiphedrin |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral, intravenous[1] |
Drug class | Sympathomimetic; Coronary vasodilator; β-Adrenergic receptor partial agonist; Norepinephrine releasing agent |
ATC code | |
Pharmacokinetic data | |
Bioavailability | Oral: 85%[1] |
Protein binding | Almost 100%[1] |
Metabolites | • Norephedrine[2] |
Elimination half-life | 4.2 hours[1] |
Excretion | Urine (active metabolites 90%)[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H23NO3 |
Molar mass | 313.397 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Oxyfedrine, sold under the brand names Ildamen and Myofedrin among others, is a sympathomimetic agent and coronary vasodilator which is used in the treatment of coronary heart disease, angina pectoris, and acute myocardial infarction.[1][3][4][5][6][7] It is taken by mouth or intravenously.[1]
The drug acts as a β-adrenergic receptor partial agonist.[1][7] It may also act as a norepinephrine releasing agent via its major active metabolite norephedrine.[2] Oxyfedrine is a phenethylamine and amphetamine derivative.[6][7]
Oxyfedrine has been marketed in Europe, Hong Kong, India, Central America, and elsewhere.[4][8][9] It appears to remain marketed only in India.[9]
AppelPlanzPalm1975
was invoked but never defined (see the help page).BeckettFoster1972
was invoked but never defined (see the help page).